Noble Corp. cuts dividend to 2 cents a share from 15 cents
bluebird bio to Present Immuno-Oncology and Gene Therapy Data at the ASGCT 19th Annual Meeting
It looks to be a fairly quiet year for capital gains payouts, but a few funds stand out.
Should you stay or should you go?
A look at some funds that have lost more than half of their assets in the past year.
Here's a look at some of the funds we've rated so far in this category.
Market volatility has shaped the performance of many top managers this year.
These mutual funds have far more than their recent success going for them.
A roundup of investment news.
Are these comeback kids for real?